Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbonyldiimidazole, which are coupling reagents used in pharmaceuticals. The company was formerly known as KPX Lifescience.Co.,Ltd. and changed its name to Green Lifescience Co., Ltd. in June 2022. The company was founded in 2005 and is headquartered in Yeosu, South Korea. Green Lifescience Co., Ltd. is a subsidiary of KPX Holdings Co., Ltd.
तुलना करने के लिए मीट्रिक्स | 114450 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध114450पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −2.6x | −1.5x | −0.5x | |
PEG अनुपात | 0.01 | 0.04 | 0.00 | |
क़ीमत/बुक | 0.9x | 1.5x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1.5x | 3.0x | 3.0x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 58.8% | 54.1% | |
उचित मूल्य अपसाइड | अनलॉक करें | 10.2% | 9.4% | अनलॉक करें |